BearFuker Profile picture
Sharing my ideas as an active daytrader focused on momentum trades with news! I will not solicit you for money, crypto and I dont offer any investment advice

Jan 12, 2022, 11 tweets

$TIVC Mega thread:

Tivic Health Systems, Inc. is a commercial-stage bioelectronic medicine company focused on treating diseases and conditions by modulating the electrical signals carried along various nerve pathways.

One of my favorite
@MrZackMorris index play

Their first FDA-cleared product, ClearUP® Sinus Pain Relief (“ClearUP”), is a patented handheld device that uses ultra-low current electrical waves to relieve sinus pain and congestion, common symptoms of sinus and nasal inflammation.

These symptoms are often associated with nasal allergies, sinus infections, chronic sinusitis, cold and flu, a $9.9 billion U.S. market currently dominated by pharmaceutical drug companies.

ClearUP is a US FDA Class II and EU Class IIa medical device that has received 3 regulatory clearances: (US FDA 510(k) # K182025, US FDA De Novo # DEN200006 and EU CE Mark Certificate # CE 704687). ClearUP is available on $AMZN $WMT $WBA $BBY and other major e-commerce websites.

Is ClearUP clinically proven?
A top-tier research center found that, 3 out of 4 users achieved sinus pain relief in 10 minutes after treatment and 82% preferred ClearUP to their current treatment. In a second clinical trial, ClearUP was shown to reduce congestion in 88% of users.

I had recently purchased the Clearup device after being a frequent sufferer of common nasal congestion and pressure myself and I found it gave me near-immediate results and I too far prefer this noninvasive method to other alternatives like congestion medicines

On 12/20/2021 $TIVC announced that they chose Mindgruve to work with Tivic Health to develop an integrated marketing and brand strategy that supports marketing and sales efforts in the U.S.

Product development activities are ongoing for two products: (i) npdPP, a home-use device for treating postoperative pain after sinus surgery, and (ii) npdMI, a home-use device for treating migraine headaches. These product candidates are still in early stages of development

Although they are carrying some debt at this time they have a decent coffer of cash on hand they stay current with their debtors and have been pulling a profit from their clearup devices. I like the fact there is high insider ownership that shows me the board has skin in the game

Chart says we have major support here near 3 and at 2.60-2.50 area. First major resistance is near 4 which will give some selling pressure from those that added to their original positions on the way down. But, ultimately a break and hold of 4 should give us 5,6 and possible ATHs

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling